CD93 signaling is a leukemia stem cell-specific regulator of self-renewal and proliferation and a targetable pathway to eliminate leukemia stem cells in chronic myeloid leukemia (16). This evidence concerns the gene CD93 and chronic myelogenous leukemia, BCR-ABL1 positive.